Physician profile
Thomas E Williams
NPI 1659479061
$521.37
in general payments reported to CMS, 2019-2025
11 companies · $48.19 in 2025
The $48.19 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.61 · 2020: $50.13 · 2021: $89.77 · 2022: $55.64 · 2023: $197 · 2024: $35.41 · 2025: $48.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $280.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $276.42 | 2020-2025 | Vraylar, Mavyret |
| Otsuka America Pharmaceutical, INC. | $37.85 | 2020-2024 | Rexulti |
| Coloplast Corp | $35.90 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.36 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $29.05 | 2023 | Seglentis, Livalo |
| Biohaven Pharmaceutical Holding Company Ltd. | $27.71 | 2022 | |
| Pfizer INC. | $23.18 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.15 | 2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.71 | 2025 | Caplyta |
| Jazz Pharmaceuticals INC. | $15.25 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.